Related Experiment Videos

Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a

John Blomberg1, Pernilla Lagergren, Lena Martin

  • 1Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. john.blomberg@karolinska.se

Gastrointestinal Endoscopy
|November 16, 2010
PubMed

Insights

Low albumin and high C-reactive protein (CRP) levels significantly increase short-term mortality risk after percutaneous endoscopic gastrostomy (PEG) procedures. This finding is crucial for patient risk assessment and decision-making before PEG insertion.

Area of Science:

  • Medical procedures
  • Gastroenterology
  • Patient outcomes

Background:

  • Percutaneous endoscopic gastrostomy (PEG) is associated with potentially severe complications.
  • Identifying risk factors for PEG complications is essential for improving patient counseling and care.

Purpose of the Study:

  • To determine if patient factors including age, body mass index, albumin, and C-reactive protein (CRP) levels influence mortality or peristomal infection risk after PEG insertion.

Main Methods:

  • A prospective cohort study was conducted from 2005 to 2009 at a university hospital.
  • The study included 484 patients undergoing PEG, with follow-up for 14 days post-procedure.
  • Outcomes assessed were 30-day mortality and 14-day peristomal infection, with risk estimates adjusted for confounding factors.

Main Results:

  • A total of 58 (12%) patients died within 30 days of PEG insertion.
  • Factors associated with increased mortality included low albumin (<30 g/L), high CRP (≥10), and age (≥65 years).
  • Patients with both low albumin and high CRP levels faced a significantly higher adjusted mortality risk (HR, 7.45; 95% CI, 2.62-21.19), with a 20.5% mortality rate compared to 2.6% in those with normal levels.

Conclusions:

  • The combination of low albumin and high CRP levels is a strong indicator of substantially increased short-term mortality risk following PEG.
  • These biochemical markers should be considered in the clinical decision-making process for patients referred for PEG placement.
Abstract